Showing 272 results

Short-run cost-effectiveness of drugs that delay disability progression in relapsing-remitting onset multiple sclerosis - working paper and assoicated secondary research material

• MS-2-802, Box 9, Folder 8
• File
• 2004-2005

Part of Murray G. Brown fonds

Societal costs of vascular cognitive impairmenr in older adults - offprint

• MS-2-802, Box 10, Folder 5
• File
• 2002

Part of Murray G. Brown fonds

Supply of physicians' service in Nova Scotia - draft report

• MS-2-802, Box 11, Folder 3
• File
• [1977]

Part of Murray G. Brown fonds

Supply of physicians' services - notes, hand-written draft

• MS-2-802, Box 16, Folder 3
• File
• [1978]

Part of Murray G. Brown fonds

Supply of physicians' services in Nova Scotia

• MS-2-802, Box 22, Folder 5
• Item
• 1987

Part of Murray G. Brown fonds

Supply of physicians' services in Nova Scotia - report drafts, notes, data tables

• MS-2-802, Box 15, Folders 1 and 2
• File
• [1975-1976]

Part of Murray G. Brown fonds

Tables and graphs on demand, supply and utilization of medical services before and after medicare

• MS-2-802, Box 1, Folder 10
• File
• 1985

Part of Murray G. Brown fonds

Tests of differences in medical care utilization rates between rural and urban counties for pre-medicare baseline year

• MS-2-802, Box 1, Folder 9
• File
• [1985]

Part of Murray G. Brown fonds

The effectiveness of MD disease-modifying drugs varies with ... everything! - draft, notes and correspondence

• MS-2-802, Box 19, Folder 9
• File
• 2009

Part of Murray G. Brown fonds

The evaluation and assessment of community health programs : an economist's perspective of evaluate activities

• MS-2-802, Box 25, Folder 6
• Item
• 1980

Part of Murray G. Brown fonds

The introduction of medicare in Canada and windfall gains to physicians - manuscript drafts and correspondence

• MS-2-802, Box 14, Folder 3
• File
• 1975-1979

Part of Murray G. Brown fonds

The New Brunswick extra-mural hospital : information for physicians

• MS-2-802, Box 26, Folder 8
• Item
• March 1988

Part of Murray G. Brown fonds

Therapies that slow disability progression in relapsing-remitting multiple sclerosis - an internal report to Aventis Pharmaceutical

• MS-2-802, Box 18, Folder 9
• File
• 2003

Part of Murray G. Brown fonds

Theraputic and economic assessement of Betaseron in mutiple sclerosis - review report, correspondence and reviews

• MS-2-802, Box 6, Folder 4
• File
• 1996

Part of Murray G. Brown fonds

Theraputic and economic assessment of Betaseron in multiple sclerosis - draft

• MS-2-802, Box 10, Folder 2
• File
• 1996

Part of Murray G. Brown fonds

Treatment of Guillain-Barrè syndrome : a cost-effectiveness analysis

• MS-2-802, Box 26, Folder 7
• Item
• 1999

Part of Murray G. Brown fonds

Treatment start and treatment duration as determinants of treatment program health outcomes and cost-effectiveness

• MS-2-802, Box 23, Folder 10
• File
• 2000

Part of Murray G. Brown fonds

Vitamin and mineral use in the Nova Scotia population age 65 and over

• MS-2-802, Box 26, Folder 12
• Item
• 1995

Part of Murray G. Brown fonds

What determines cost-effectiveness of novel multiple sclerosis drugs? - seminar presentation, Dalhousie Department of Economics, International Health Economics Conference (York, UK)

• MS-2-802, Box 16, Folder 10
• File
• 2001

Part of Murray G. Brown fonds

What determines cost-effectiveness of novel multple sclerosis drugs - presentation for health economics seminar and workshop in Sodertalje, Sweden

• MS-2-802, Box 16, Folder 5
• File
• 1980

Part of Murray G. Brown fonds

Work time lost by Ports Canada employees : a study of disability time lost by Port of Halifax employees

• MS-2-802, Box 25, Folder 4
• Item
• 1982

Part of Murray G. Brown fonds

Work-time lost by Ports Canada employees : a study of disability time lost by Port of Halifax employees - report and raw data

• MS-2-802, Box 14, Folder 6; Box 3, Folder 9
• File
• 1982

Part of Murray G. Brown fonds